165 related articles for article (PubMed ID: 36458365)
1. Clinical value of long non-coding RNA KCNQ1OT1 in estimating the stenosis, lipid level, inflammation status, and prognostication in coronary heart disease patients.
Zhu L; Feng Q; Fan J; Huang J; Zhu Y; Wu Y; Hou A; Huo Y
J Clin Lab Anal; 2023 Jan; 37(1):e24775. PubMed ID: 36458365
[TBL] [Abstract][Full Text] [Related]
2. Increased long non-coding RNA NORAD reflects serious cardiovascular stenosis, aggravated inflammation status, and higher lipid level in coronary heart disease.
Zhang X; Kan X; Shen J; Li J
J Clin Lab Anal; 2022 Nov; 36(11):e24717. PubMed ID: 36319574
[TBL] [Abstract][Full Text] [Related]
3. Circulating brain-derived neurotrophic factor dysregulation and its linkage with lipid level, stenosis degree, and inflammatory cytokines in coronary heart disease.
Xia F; Zeng Q; Chen J
J Clin Lab Anal; 2022 Jul; 36(7):e24546. PubMed ID: 35666604
[TBL] [Abstract][Full Text] [Related]
4. Correlation of Long Non-coding RNA LncRNA-FA2H-2 With Inflammatory Markers in the Peripheral Blood of Patients With Coronary Heart Disease.
Guo F; Sha Y; Hu B; Li G
Front Cardiovasc Med; 2021; 8():682959. PubMed ID: 34235188
[No Abstract] [Full Text] [Related]
5. The interplay of long noncoding RNA HULC with microRNA-128-3p and their correlations with lipid level, stenosis degree, inflammatory cytokines, and cell adhesion molecules in coronary heart disease patients.
Zhu X; Hu J; Xie L
Ir J Med Sci; 2022 Dec; 191(6):2597-2603. PubMed ID: 35088229
[TBL] [Abstract][Full Text] [Related]
6. Long non-coding RNA MALAT1 and its target microRNA-125b associate with disease risk, severity, and major adverse cardiovascular event of coronary heart disease.
Lv F; Liu L; Feng Q; Yang X
J Clin Lab Anal; 2021 Apr; 35(4):e23593. PubMed ID: 33660877
[TBL] [Abstract][Full Text] [Related]
7. Up-regulation of long non-coding RNA THRIL in coronary heart disease: Prediction for disease risk, correlation with inflammation, coronary artery stenosis, and major adverse cardiovascular events.
Qi H; Shen J; Zhou W
J Clin Lab Anal; 2020 May; 34(5):e23196. PubMed ID: 31944373
[TBL] [Abstract][Full Text] [Related]
8. LncRNA NEAT1 correlates with Th17 cells and proinflammatory cytokines, also reflects stenosis degree and cholesterol level in coronary heart disease patients.
Zhu L; Lin X; Chen M
J Clin Lab Anal; 2022 Jun; 36(6):e23975. PubMed ID: 35478415
[TBL] [Abstract][Full Text] [Related]
9. LncRNA UCA1, miR-26a, and miR-195 in coronary heart disease patients: Correlation with stenosis degree, cholesterol levels, inflammatory cytokines, and cell adhesion molecules.
Li J; Chen Z; Wang X; Song H
J Clin Lab Anal; 2022 Jan; 36(1):e24070. PubMed ID: 34850451
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-34a in coronary heart disease: Correlation with disease risk, blood lipid, stenosis degree, inflammatory cytokines, and cell adhesion molecules.
Li H; Chen M; Feng Q; Zhu L; Bai Z; Wang B; Guo Z; Hou A; Li H
J Clin Lab Anal; 2022 Jan; 36(1):e24138. PubMed ID: 34861059
[TBL] [Abstract][Full Text] [Related]
11. Relation of circulating lncRNA GAS5 and miR-21 with biochemical indexes, stenosis severity, and inflammatory cytokines in coronary heart disease patients.
Jiang Y; Du T
J Clin Lab Anal; 2022 Feb; 36(2):e24202. PubMed ID: 34997773
[TBL] [Abstract][Full Text] [Related]
12. Serum ITIH4 in coronary heart disease: a potential anti-inflammatory biomarker related to stenosis degree and risk of major adverse cardiovascular events.
Huo Y; Lai Y; Feng Q; Wang Q; Li J
Biomark Med; 2022 Dec; 16(18):1279-1288. PubMed ID: 36891881
[TBL] [Abstract][Full Text] [Related]
13. Linkage of Blood MALT1 with CD4+ T Cell Subset, Inflammation, Lipid, and Its Potency as a Biomarker for Predicting Major Adverse Cardiovascular Events in Coronary Heart Disease Patients.
Zhang L; Li J; Yang Z; Wang S; Liu J; Luan S; Tian G
Ann Clin Lab Sci; 2023 Jul; 53(4):507-515. PubMed ID: 37625844
[TBL] [Abstract][Full Text] [Related]
14. The relation of circulating cell division cycle 42 expression with Th1, Th2, and Th17 cells, adhesion molecules, and biochemical indexes in coronary heart disease patients.
Zhou M; Wu J; Tan G
Ir J Med Sci; 2022 Oct; 191(5):2085-2090. PubMed ID: 34811660
[TBL] [Abstract][Full Text] [Related]
15. Circulating HDAC4 reflects lipid profile, coronary stenosis and inflammation in coronary heart disease patients.
Guo Z; Wu Y; Feng Q; Wang C; Wang Z; Zhu Y; Lu X; Chen W; Yang Q; Huo Y
Biomark Med; 2023 Jan; 17(1):41-49. PubMed ID: 37013891
[TBL] [Abstract][Full Text] [Related]
16. Serum Exosomal MicroRNA-186-5p Positively Correlates with Lipid Indexes, Coronary Stenosis Degree, and Major Adverse Cardiovascular Events in Coronary Heart Disease.
Ren L; Liu W; Chen S; Zeng H
Tohoku J Exp Med; 2024 Feb; 262(2):97-103. PubMed ID: 38057119
[TBL] [Abstract][Full Text] [Related]
17. Potential of long non-coding RNA KCNQ1OT1 as a biomarker reflecting systemic inflammation, multiple organ dysfunction, and mortality risk in sepsis patients.
Jiao W; Zhou X; Wu J; Zhang X; Ding J
J Clin Lab Anal; 2021 Dec; 35(12):e24047. PubMed ID: 34761437
[TBL] [Abstract][Full Text] [Related]
18. KCNQ1OT1, HIF1A-AS2 and APOA1-AS are promising novel biomarkers for diagnosis of coronary artery disease.
Zhang Y; Zhang L; Wang Y; Ding H; Xue S; Yu H; Hu L; Qi H; Wang Y; Zhu W; Liu D; Li P
Clin Exp Pharmacol Physiol; 2019 Jul; 46(7):635-642. PubMed ID: 30941792
[TBL] [Abstract][Full Text] [Related]
19. Serum YKL-40 in coronary heart disease: linkage with inflammatory cytokines, artery stenosis, and optimal cut-off value for estimating major adverse cardiovascular events.
Song M; Zhang G; Shi H; Zhu E; Deng L; Shen H
Front Cardiovasc Med; 2023; 10():1242339. PubMed ID: 38028459
[TBL] [Abstract][Full Text] [Related]
20. Circulating lncRNA IFNG-AS1 expression correlates with increased disease risk, higher disease severity and elevated inflammation in patients with coronary artery disease.
Xu Y; Shao B
J Clin Lab Anal; 2018 Sep; 32(7):e22452. PubMed ID: 29744951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
